Ucar G - Search Results

1

Absolute configuration and biological profile of pyrazoline enantiomers as MAO inhibitory activity.

Goksen US, Sarigul S, Bultinck P, Herrebout W, Dogan I, Yelekci K, Ucar G, Gokhan Kelekci N. Goksen US, et al. Among authors: ucar g. Chirality. 2019 Jan;31(1):21-33. doi: 10.1002/chir.23027. Epub 2018 Nov 23. Chirality. 2019. PMID: 30468523

2

1-N-substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: synthesis and evaluation as MAO inhibitors.

Gökhan N, Yeşilada A, Uçar G, Erol K, Bilgin AA. Gökhan N, et al. Among authors: ucar g. Arch Pharm (Weinheim). 2003 Aug;336(8):362-71. doi: 10.1002/ardp.200300732. Arch Pharm (Weinheim). 2003. PMID: 14502756

3

1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: a novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases.

Ucar G, Gokhan N, Yesilada A, Bilgin AA. Ucar G, et al. Neurosci Lett. 2005 Jul 15;382(3):327-31. doi: 10.1016/j.neulet.2005.03.028. Epub 2005 Apr 12. Neurosci Lett. 2005. PMID: 15925113

4

Interaction of rat lung SSAO with the novel 1-N-substituted thiocarbamoyl-3-substituted phenyl-5-(2-pyrolyl)-2-pyrazoline derivatives.

Yabanoglu S, Ucar G, Gokhan N, Salgin U, Yesilada A, Bilgin AA. Yabanoglu S, et al. Among authors: ucar g. J Neural Transm (Vienna). 2007;114(6):769-73. doi: 10.1007/s00702-007-0686-8. Epub 2007 Mar 26. J Neural Transm (Vienna). 2007. PMID: 17385065

5

Monoamine oxidase inhibitory activities of novel 3,4-dihydroquinolin-(1H)-2-one derivatives.

Sunal SG, Yabanoglu S, Yesilada A, Ucar G. Sunal SG, et al. Among authors: ucar g. J Neural Transm (Vienna). 2007;114(6):717-9. doi: 10.1007/s00702-007-0677-9. Epub 2007 Mar 26. J Neural Transm (Vienna). 2007. PMID: 17385067

6

A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics.

Gökhan-Kelekçi N, Yabanoğlu S, Küpeli E, Salgin U, Ozgen O, Uçar G, Yeşilada E, Kendi E, Yeşilada A, Bilgin AA. Gökhan-Kelekçi N, et al. Among authors: ucar g. Bioorg Med Chem. 2007 Sep 1;15(17):5775-86. doi: 10.1016/j.bmc.2007.06.004. Epub 2007 Jun 8. Bioorg Med Chem. 2007. PMID: 17611112

7

Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives.

Palaska E, Aydin F, Uçar G, Erol D. Palaska E, et al. Among authors: ucar g. Arch Pharm (Weinheim). 2008 Apr;341(4):209-15. doi: 10.1002/ardp.200700159. Arch Pharm (Weinheim). 2008. PMID: 18266289

8

New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.

Gökhan-Kelekçi N, Koyunoğlu S, Yabanoğlu S, Yelekçi K, Ozgen O, Uçar G, Erol K, Kendi E, Yeşilada A. Gökhan-Kelekçi N, et al. Among authors: ucar g. Bioorg Med Chem. 2009 Jan 15;17(2):675-89. doi: 10.1016/j.bmc.2008.11.068. Epub 2008 Dec 3. Bioorg Med Chem. 2009. PMID: 19091581

9

Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.

Gökhan-Kelekçi N, Simşek OO, Ercan A, Yelekçi K, Sahin ZS, Işik S, Uçar G, Bilgin AA. Gökhan-Kelekçi N, et al. Among authors: ucar g. Bioorg Med Chem. 2009 Sep 15;17(18):6761-72. doi: 10.1016/j.bmc.2009.07.033. Epub 2009 Jul 23. Bioorg Med Chem. 2009. PMID: 19682910

10

Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.

Sahoo A, Yabanoglu S, Sinha BN, Ucar G, Basu A, Jayaprakash V. Sahoo A, et al. Among authors: ucar g. Bioorg Med Chem Lett. 2010 Jan 1;20(1):132-6. doi: 10.1016/j.bmcl.2009.11.015. Epub 2009 Nov 12. Bioorg Med Chem Lett. 2010. PMID: 19945874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

136 results

Search Page